ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients
Zongshun Chen, Jing Zhang, Wei Chen, Xueyi Chen, Da-Lin Lu, Junjie Li
Springer Nature ·
2025-03-24
· DOI 10.1245/s10434-025-17243-7
The publisher did not provide an abstract — full text is available via the link below.
Zongshun Chen, Jing Zhang, Wei Chen, Xueyi Chen, Da-Lin Lu, Junjie Li. ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients. // Annals of Surgical Oncology. – 2025. – DOI: 10.1245/s10434-025-17243-7. – URL: https://doi.org/10.1245/s10434-025-17243-7
Zongshun Chen, Jing Zhang, Wei Chen, Xueyi Chen, Da-Lin Lu, & Junjie Li (2025). ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-025-17243-7
Zongshun Chen, et al. “ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients.” Annals of Surgical Oncology, 2025. doi:10.1245/s10434-025-17243-7.
@article{Chen2025,
title = {ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients},
author = {Chen, Zongshun and Zhang, Jing and Chen, Wei and Chen, Xueyi and Lu, Da-Lin and Li, Junjie},
journal = {Annals of Surgical Oncology},
year = {2025},
doi = {10.1245/s10434-025-17243-7},
url = {https://doi.org/10.1245/s10434-025-17243-7}
}